Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $) In Thousands, unless otherwise specified	6 Months Ended
	May 04, 2013	May 05, 2012
Cash flows from operating activities:
Net income	$ 295,694	$ 302,281
Adjustments to reconcile net income to net cash provided by operations:
Depreciation	55,233	55,114
Amortization of intangibles	110	18
Stock-based compensation expense	31,017	25,432
Gain on sale of investments	0	(1,231)
Excess tax benefit-stock options	(8,808)	(4,498)
Deferred income taxes	(10,402)	(4,139)
Other non-cash activity	(1,382)	(390)
Changes in operating assets and liabilities	48,693	68,202
Total adjustments	114,461	138,508
Net cash provided by operating activities	410,155	440,789
Cash flows from investing activities:
Purchases of short-term available-for-sale investments	(3,856,909)	(4,428,475)
Maturities of short-term available-for-sale investments	3,277,635	3,295,587
Sales of short-term available-for-sale investments	374,515	261,575
Proceeds from the sale of investments	0	(1,506)
Additions to property, plant and equipment	(44,448)	(55,426)
Payments for acquisitions, net of cash acquired	0	(24,158)
(Increase) decrease in other assets	(2,526)	(1,323)
Net cash (used for) provided by investing activities	(251,733)	(950,714)
Cash flows from financing activities:
Early termination of swap agreements	0	18,520
Term loan repayments	(60,108)	(19,250)
Dividend payments to shareholders	(195,094)	(163,818)
Repurchase of common stock	(21,520)	(122,734)
Proceeds from employee stock plans	176,025	87,736
Contingent consideration payment	(3,752)	(1,991)
(Decrease) increase in other financing activities	3,157	(1,989)
Excess tax benefit-stock options	8,808	4,498
Net cash used for financing activities	(92,484)	(199,028)
Effect of exchange rate changes on cash	860	(1,081)
Net (decrease) increase in cash and cash equivalents	66,798	(710,034)
Cash and cash equivalents at beginning of period	528,833	1,405,100
Cash and cash equivalents at end of period	$ 595,631	$ 695,066